V593 Home HD water and dialysate: onsite evaluation
Written V0593 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§ 494.100(c) Standard: Support services. (1) …Services include, but are not limited to, the following: (v) Monitoring of the quality of water and dialysate used by home hemodialysis patients including conducting an onsite evaluation and . . .
CMS's interpretive guidance
Interpretive Guidance § 494.100 (c)(1)(v):
At the time of publishing these regulations (April 15, 2008, 73 FR 20369), several different technologies for home hemodialysis were available. These included: conventional water treatment components and single-pass (conventional) dialysis machines; integrated systems which used manufacturer packaged, bagged dialysate or which incorporated water treatment and dialysate preparation and delivery into one system; and, sorbent-based systems which utilized columns (cartridges) of chemicals to regenerate the used dialysate for recirculation through the dialyzer. All of these, and any future home hemodialysis technologies developed, present the home dialysis facility with both common and unique challenges for monitoring to ensure the continued efficacy and safety of the home hemodialysis patients’ treatments. Because of their differences, the Interpretive Guidance for the following tags (V593-V598) at times refers to one or more of the above-mentioned home hemodialysis technologies as related to the specific requirements and/or exclusions from certain requirements.
Hemodialysis in the home requires specific infrastructure and organization of plumbing and water. The facility home training staff must monitor the quality of water and dialysate used by home hemodialysis patients and conduct on-site evaluations of the home hemodialysis patient’s water supply prior to selecting a water treatment system for home hemodialysis to ensure sufficient infrastructure is in place to deliver safe and effective dialysis treatments. Sufficient infrastructure should include, but is not limited to: water supply that can meet the temperature and water pressure demands, stable electrical supply to accommodate hemodialysis, and plumbing requirements to ensure appropriate fittings and installations.
There should be evidence the source water to be used meets the minimum requirements specified by the manufacturer of the water treatment components or of the integrated system, if such is in use. If the source water requirements are not met, there needs to be adequate pre-treatment of the source water to meet those requirements.
Each home water treatment system must include either an RO or a DI treatment component or alternate technology that achieves AAMI standards, and a method to remove metals and chemicals such as chlorine/chloramines.
According to AAMI RD52:2004/Annex C: Special considerations for home hemodialysis at C.3.1 Water supply, if the home is served by a small water system (serving less than 3000 persons), or one classified as an economically or socially-disadvantaged system (serving less than 500 persons), the water entering the residence is not regulated by the EPA Safe Drinking Water Act. Additionally, any municipal system may have received a variance, which can be granted by State drinking water programs for chemical contaminants. If the water is supplied from an individual well, the EPA standard may not be met.
Due to these variables affecting the regulation of the water supply to a home for safe drinking water standards, an annual analysis of the product water quality may not be sufficient. This is because the quality of water from the well can change over time, and private wells are not routinely monitored. More frequent analysis may be needed if the well is subject to seasonal changes or contamination from sources such as septic tanks, underground fuel storage tanks, or agricultural waste and chemicals. The additional monitoring may not require a full AAMI analysis if only certain contaminants are known to be of concern.
The home patient’s record must include review and acknowledgement of any problems with the source water, and a monitoring schedule for the source water. The patient’s physician should demonstrate awareness of any issues with the source water, and the plan of care should address any issues with source water for the home HD patient.
The home evaluation should address the storage of supplies, including dialysate concentrate(s). The storage area should provide a year-round environment that meets the manufacturer’s recommendations for storing supplies.
For home water treatment systems, guidance is found under the Condition for Water and dialysate quality at V595, which highlights the recommendations in ANSI/AAMI RD52:2004: Annex C “Special considerations for home hemodialysis.”
Connected tags
V593 to V598, the range named above
Questions on this site that cite it
Rulebook subjects that cite it
https://middlemolecule.com/rulebook/tags/v593/